← Back to news
NewsSIGNAL TRANSDUCTION AND TARGETED THERAPYSunday, February 22, 2026 · February 22, 2026

Parathyroid hormone-related protein is a therapeutic target in idiopathic pulmonary fibrosis.

WHY IT MATTERS

Recent peer-reviewed research on Idiopathic pulmonary fibrosis that may be relevant for patients and caregivers.

The crosstalk between immune or alveolar epithelial cells and fibroblasts mediated by paracrine signaling molecules is associated with the pathogenesis of idiopathic pulmonary fibrosis (IPF). However, studies investigating the active involvement of soluble mediators derived from bronchial epithelial...

Read on PubMed
Read the original at Signal transduction and targeted therapy
ResearchPubMedIdiopathic pulmonary fibrosisParathyroid Hormone-Related ProteinIdiopathic Pulmonary Fibrosis

Related conditions

Idiopathic pulmonary fibrosis

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.